2019
DOI: 10.1101/577759
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Cell type-specific monoclonal antibody cross-reactivity screening in non-human primates and development of comparative immunophenotyping panels for CyTOF

Abstract: IntroductionNon-human primates (NHPs) are critical components of drug development because of their similarity to humans. Many key immunology assays, such as flow cytometry, Western blots, immunohistochemistry and immunofluorescence microscopy, make use of antibodies to demarcate specific cell types and quantify signaling moieties. Very few antibodies are raised against non-human primate antigens; instead, researchers typically use anti-human antibodies that are cross-reactive with the non-human primate species… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(13 citation statements)
references
References 27 publications
0
11
0
Order By: Relevance
“…Given the scarcity of PBMCs from patients with EVD, we wanted to use an established mass cytometry panel for these studies rather than developing and validating a new panel. The panel chosen was developed for use in human immunology studies (43,44). It contains of a series of surface antibodies for phenotypically classifying cells and a series of phospho-specific antibodies for evaluating intracellular signaling pathways (see Supplemental Table 1 for antibody details; supplemental material available online with this article; https:// doi.org/10.1172/jci.insight.137260DS1).…”
Section: Resultsmentioning
confidence: 99%
“…Given the scarcity of PBMCs from patients with EVD, we wanted to use an established mass cytometry panel for these studies rather than developing and validating a new panel. The panel chosen was developed for use in human immunology studies (43,44). It contains of a series of surface antibodies for phenotypically classifying cells and a series of phospho-specific antibodies for evaluating intracellular signaling pathways (see Supplemental Table 1 for antibody details; supplemental material available online with this article; https:// doi.org/10.1172/jci.insight.137260DS1).…”
Section: Resultsmentioning
confidence: 99%
“…We aspirated pelleted barcoded cells to a volume of 50 μL and incubated them with 15 μL of Human TruStain FcX (Biolegend, San Diego, CA) for 10 minutes. We stained cells for 30 min with 175 μL of a reconstituted lyophilized cocktail of metal-tagged cell-surface antibodies described previously ( Bjornson-Hooper et al., 2019a , 2019b ) supplemented with two additional antibody channels ( Data S1 ). We washed and permeabilized surface-stained cells with methanol before aspirating down to 50 μL and staining for 60 min with 190 μL of reconstituted lyophilized intracellular staining antibody cocktail ( Data S1 ).…”
Section: Methodsmentioning
confidence: 99%
“…We aspirated pelleted barcoded cells to a volume of 50 µL and incubated them with 15 µL of Human TruStain FcX (Biolegend, San Diego, CA) for 10 minutes. We stained cells for 30 min with 175 µL of a reconstituted lyophilized cocktail of metal-tagged cell-surface antibodies described previously (Bjornson-Hooper et al, 2019a, 2019b supplemented with two additional antibody channels ( Table S7 ). We washed and permeabilized surface-stained cells with methanol before aspirating down to 50 µL and staining for 60 min with 190 µL of reconstituted lyophilized intracellular staining antibody cocktail (Bjornson-Hooper et al, 2019a, 2019b ( Table S7 ).…”
Section: Cytofmentioning
confidence: 99%